Harrow (HROW) Earnings Date & Reports

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

HROW is expected to report earnings to fall 142.13% to 19 cents per share on November 16

Q3'26

Est.

$0.19

Q2'26

Missed

by $0.35

Q1'26

Missed

by $0.39

Q4'25

Missed

by $0.22

Q3'25

Beat

by $0.09

The last earnings report on August 10 showed earnings per share of -46 cents, missing the estimate of -10 cents. With 181.61K shares outstanding, the current market capitalization sits at 1.24B.

View a ticker or compare two or three

HROW

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for HROW